Kampmann’s goal is to understand the molecular mechanisms driving neurodegenerative diseases such as Alzheimer’s and Parkinson’s. He is developing cell-based models of neurodegenerative disease processes in human induced pluripotent stem cells and is carrying out CRISPRi screens to identify underlying neuron-specific processes.
BACK TO ALL
MARTIN KAMPMANN, PH.D.

Scientific Advisory Board
GET CZ BIOHUB UPDATES IN YOUR INBOX
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.